Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU
Summary
Pratteln, Switzerland, April 27, 2026 - Santhera Pharmaceuticals (SIX: SANN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of t...
Description
Pratteln, Switzerland, April 27, 2026 - Santhera Pharmaceuticals (SIX: SANN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of t...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source